IL124881A0 - Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer - Google Patents

Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Info

Publication number: IL124881A0
Authority: IL; Israel
Prior art keywords: centchroman; enantiomer; prophylaxis; manufacture; treatment
Prior art date: 1996-01-11

Application number

IL12488197A

Other languages

English (en)

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-11

Filing date

1997-01-09

Publication date

1999-01-26

1997-01-09 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1999-01-26 Publication of IL124881A0 publication Critical patent/IL124881A0/xx

Links

206010006187 Breast cancer Diseases 0.000 title 1
208000026310 Breast neoplasm Diseases 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
XZEUAXYWNKYKPL-URLMMPGGSA-N ormeloxifene Chemical compound C1([C@@H]2[C@H](C3=CC=C(C=C3OC2(C)C)OC)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 XZEUAXYWNKYKPL-URLMMPGGSA-N 0.000 title 1
229960003327 ormeloxifene Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
238000011282 treatment Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL12488197A 1996-01-11 1997-01-09 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer IL124881A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1000096P	1996-01-11	1996-01-11
DK77696		1996-07-11
PCT/DK1997/000007 WO1997025034A1 (en)	1996-01-11	1997-01-09	Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Publications (1)

Publication Number	Publication Date
IL124881A0 true IL124881A0 (en)	1999-01-26

Family

ID=26064631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12488197A IL124881A0 (en)	1996-01-11	1997-01-09	Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Country Status (12)

Country	Link
EP (1)	EP0873119A1 (ko)
JP (1)	JP2001500101A (ko)
KR (1)	KR19990077157A (ko)
AU (1)	AU1367197A (ko)
BR (1)	BR9706966A (ko)
CA (1)	CA2241462A1 (ko)
CZ (1)	CZ217198A3 (ko)
HU (1)	HUP9901633A3 (ko)
IL (1)	IL124881A0 (ko)
NO (1)	NO983177L (ko)
PL (1)	PL328135A1 (ko)
WO (1)	WO1997025034A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1028724A1 (en) *	1997-11-10	2000-08-23	Novo Nordisk A/S	Transdermal delivery of 3,4-diarylchromans
US6465445B1 (en)	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2004200099B2 (en) *	1998-06-11	2006-11-02	Endorecherche, Inc.	Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
AU2011253842B2 (en) *	1998-06-11	2014-08-14	Endorecherche Inc.	Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CN106038572A (zh)	2004-10-20	2016-10-26	恩多研究公司	性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
US8268806B2 (en)	2007-08-10	2012-09-18	Endorecherche, Inc.	Pharmaceutical compositions
MX2010004195A (es)	2007-10-16	2010-06-02	Repros Therapeutics Inc	Trans-clomifeno para el sindrome metabolico.
US20100317635A1 (en)	2009-06-16	2010-12-16	Endorecherche, Inc.	Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
SG186333A1 (en)	2010-06-16	2013-01-30	Endorech Inc	Methods of treating or preventing estrogen-related diseases
MX2014009322A (es)	2012-02-29	2014-11-10	Repros Therapeutics Inc	Terapia de combinacion para el tratamiento de la deficiencia androgenica.
US9744177B2 (en)	2014-03-10	2017-08-29	Endorecherche, Inc.	Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US11633382B2 (en)	2015-11-10	2023-04-25	Paracrine Therapeutics Ab	Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4447622A (en) *	1981-09-22	1984-05-08	Council Of Scientific And Industrial Research Rafi Marg	Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

1997
- 1997-01-09 AU AU13671/97A patent/AU1367197A/en not_active Abandoned
- 1997-01-09 CZ CZ982171A patent/CZ217198A3/cs unknown
- 1997-01-09 HU HU9901633A patent/HUP9901633A3/hu unknown
- 1997-01-09 EP EP97900199A patent/EP0873119A1/en not_active Withdrawn
- 1997-01-09 CA CA002241462A patent/CA2241462A1/en not_active Abandoned
- 1997-01-09 IL IL12488197A patent/IL124881A0/xx unknown
- 1997-01-09 BR BR9706966A patent/BR9706966A/pt not_active Application Discontinuation
- 1997-01-09 PL PL97328135A patent/PL328135A1/xx unknown
- 1997-01-09 JP JP09524767A patent/JP2001500101A/ja active Pending
- 1997-01-09 KR KR1019980705295A patent/KR19990077157A/ko not_active Withdrawn
- 1997-01-09 WO PCT/DK1997/000007 patent/WO1997025034A1/en not_active Ceased
1998
- 1998-07-10 NO NO983177A patent/NO983177L/no unknown

Also Published As

Publication number	Publication date
NO983177L (no)	1998-07-10
BR9706966A (pt)	1999-05-04
HUP9901633A3 (en)	2000-02-28
JP2001500101A (ja)	2001-01-09
AU1367197A (en)	1997-08-01
PL328135A1 (en)	1999-01-18
HUP9901633A2 (hu)	1999-10-28
KR19990077157A (ko)	1999-10-25
CA2241462A1 (en)	1997-07-17
EP0873119A1 (en)	1998-10-28
WO1997025034A1 (en)	1997-07-17
CZ217198A3 (cs)	1998-11-11

Publication	Publication Date	Title
EP0942742A4 (en)	2003-01-08	THERAPEUTIC COMPOSITIONS FOR CANCER TREATMENT
IL112969A0 (en)	1995-06-29	Pharmaceutical composition comprising t-cell actiVator for the treatment of cancer
AP9700939A0 (en)	1997-04-30	Compounds and methods for the treatment of cancer
HUP9903166A3 (en)	2003-09-29	Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
AU1980995A (en)	1995-09-25	Methods and compositions for treatment of breast cancer
ZA952356B (en)	1996-10-21	Skin treatment composition
IL132287A0 (en)	2001-03-19	Compositions and methods for the treatment and diagnosis of breast cancer
HUP9901633A3 (en)	2000-02-28	Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
HUP9802861A3 (en)	1999-08-30	Use of calendula glycosides for the treatment of psoriasis
AU5005197A (en)	1998-05-22	Prophylaxis of breast cancer
ZA952121B (en)	1996-09-16	Skin treatment composition
IL121329A0 (en)	1999-10-28	A pharmaceutical composition for the treatment of cancer
GB9510162D0 (en)	1995-07-12	Compositions for the treatment of skin conditions
GB9106170D0 (en)	1991-05-08	New compounds for use in the treatment of cancer
ZA97215B (en)	1997-07-21	Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
GB9405046D0 (en)	1994-04-27	Skin treatment composition
GB2312375B (en)	1998-02-25	Agents for treatment of cancer
HU9700079D0 (en)	1997-02-28	Topical compositions for the treatment of skin disease
ZA979720B (en)	1999-04-29	Prophylaxis of breast cancer
EP0460690A3 (en)	1992-04-22	Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
IL123422A (en)	2003-05-29	USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
IL115200A0 (en)	1995-12-31	Pharmaceutical compositions for the treatment of cancer
IL124488A0 (en)	1998-12-06	A preparation for the treatment of psoriasis
HUP9801868A3 (en)	1999-05-28	Use of droloxifene for prevention of breast cancer
PL311159A1 (en)	1996-02-05	Pharmaceutical composition for treating psoriasis